bromodeoxyuridine has been researched along with B16 Melanoma in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (19.05) | 18.7374 |
| 1990's | 10 (47.62) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Hamana, H; Hayakawa, Y; Kishi, H; Lyu, F; Mojic, M; Ohshima, C; Shitaoka, K; Tahara, H; Ucche, S | 1 |
| Hirayama, R; Kashino, G; Kinashi, Y; Liu, Y; Maruhashi, A; Masunaga, S; Matsumoto, Y; Ono, K; Sakurai, Y; Suzuki, M; Tanaka, H | 1 |
| Chen, L; Gao, X; Huang, CH; Huang, SL; Lu, Y; Punchard, NA; Sun, ZG; Wang, AY; Zheng, SZ | 1 |
| Kinashi, Y; Kondo, N; Liu, Y; Maruhashi, A; Masunaga, S; Ono, K; Sakurai, Y; Suzuki, M; Tanaka, H | 1 |
| Chiu, LC; Ooi, VE; Tong, KF | 1 |
| Holy, J; Oliveira, PJ; Parke, D; Perkins, E; Sardao, VA; Serafim, TL | 1 |
| Gómez, LA; Rieber, M; Strasberg Rieber, M | 1 |
| Rieber, M; Rieber, MS | 2 |
| Hagiwara, A; Ohyama, T; Osaki, K; Sakakibara, T; Sakakura, C; Sasaki, S; Shimotsuma, M; Shirasu, M; Takhashi, T; Tsujimoto, H | 1 |
| Futamura, Y; Kurokawa, M; Obata, M; Shibutani, Y | 1 |
| Davidson, RL; Rauth, S | 1 |
| Clairmont, C; Hellstrand, K; Hirschberg, C; Olofsson, S; Shugar, D; Sjöblom, I | 1 |
| Chelladurai, M; Drelichman, A; Hanna, Y; Lobocki, CA; McLaughlin, PW; Pieper, DR; Sultani, M | 1 |
| Rieber, M; Strasberg-Rieber, M | 1 |
| Katoh, O; Kawashima, Y; Ohara, M; Watanabe, H | 1 |
| Davidson, RL; Hoganson, GE; Rauth, S | 1 |
| Lira, R; Rieber, M; Rieber, MS; Urbina, C | 1 |
| Kinoshita, Y; Sato, S; Takeuchi, T | 1 |
| Mann, GJ; Tattersall, MH; Wong, WS | 1 |
| Vítek, JA | 1 |
21 other study(ies) available for bromodeoxyuridine and B16 Melanoma
| Article | Year |
|---|---|
NKG2D defines tumor-reacting effector CD8
Topics: Animals; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Bromodeoxyuridine; CD8-Positive T-Lymphocytes; Interferon-gamma; Luciferases; Luminescent Measurements; Lymphocytes, Tumor-Infiltrating; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; NK Cell Lectin-Like Receptor Subfamily K; Ovalbumin; Skin Neoplasms; Tumor Microenvironment; Vaccination | 2021 |
Significance of manipulating tumour hypoxia and radiation dose rate in terms of local tumour response and lung metastatic potential, referring to the response of quiescent cell populations.
Topics: Animals; Bromodeoxyuridine; Cell Hypoxia; Combined Modality Therapy; Female; Gamma Rays; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Niacinamide; Radiotherapy Dosage; Temperature; Tumor Cells, Cultured | 2010 |
Cryptotanshinone has diverse effects on cell cycle events in melanoma cell lines with different metastatic capacity.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; Female; Genes, ras; Lung Neoplasms; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Phenanthrenes; Proto-Oncogene Proteins B-raf; Salvia miltiorrhiza | 2011 |
Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.
Topics: Animals; Antineoplastic Agents; Borohydrides; Boron Neutron Capture Therapy; Bromodeoxyuridine; Cell Hypoxia; Female; Hyperthermia, Induced; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Niacinamide; Radiation-Sensitizing Agents; Skin Neoplasms; Sulfhydryl Compounds; Vitamin B Complex | 2012 |
Cytostatic and cytotoxic effects of cyclooxygenase inhibitors and their synergy with docosahexaenoic acid on the growth of human skin melanoma A-375 cells.
Topics: Antineoplastic Agents; Aspirin; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase Inhibitors; Docosahexaenoic Acids; Drug Synergism; Humans; Indomethacin; Melanoma, Experimental; Piroxicam; Skin Neoplasms; Tetrazolium Salts; Thiazoles | 2005 |
Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line.
Topics: Animals; Antimetabolites; Berberine; Bromodeoxyuridine; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cell Cycle; Cell Death; Cell Division; Cell Line, Tumor; Cell Proliferation; DNA; Humans; Melanoma, Experimental; Mice; Microscopy, Fluorescence; Mitochondria; Uncoupling Agents | 2008 |
Decrease in actin gene expression in melanoma cells compared to melanocytes is partly counteracted by BrdU-induced cell adhesion and antagonized by L-tyrosine induction of terminal differentiation.
Topics: Actins; Animals; Bromodeoxyuridine; Cell Adhesion; Cell Differentiation; Cells, Cultured; Gene Expression Regulation, Neoplastic; Melanocytes; Melanoma, Experimental; Mice; Mice, Inbred C57BL; RNA, Messenger; Tyrosine; Ultraviolet Rays | 1995 |
UV radiation induces DNA fragmentation and cell death in B16 melanoma sensitized by bromodeoxyuridine: impaired c-jun induction and defective tyrosine phosphorylation signalling.
Topics: Animals; Bromodeoxyuridine; Cell Death; Cell Survival; DNA Damage; DNA, Neoplasm; Ethers, Cyclic; Genes, jun; Immunoblotting; Melanoma, Experimental; Mice; Okadaic Acid; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins c-jun; Radiation-Sensitizing Agents; Signal Transduction; Tumor Cells, Cultured; Tyrosine; Ultraviolet Rays; Vanadates | 1994 |
Site-specific implantation in the milky spots of malignant cells in peritoneal dissemination: immunohistochemical observation in mice inoculated intraperitoneally with bromodeoxyuridine-labelled cells.
Topics: Animals; Bromodeoxyuridine; Female; Injections, Intraperitoneal; Leukemia P388; Lymphoid Tissue; Male; Melanoma, Experimental; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Neoplasm Invasiveness; Neoplasm Transplantation; Omentum; Organ Specificity; Peritoneal Neoplasms; Sensitivity and Specificity; Staining and Labeling | 1995 |
Re: Enhanced cancer growth in mice administered daily human-equivalent doses of some H1-antihistamines: predictive in vitro correlates.
Topics: Animals; Astemizole; Bromodeoxyuridine; Fibrosarcoma; Histamine H1 Antagonists; Melanoma, Experimental; Mice; Mice, Inbred Strains; Reproducibility of Results; Sarcoma, Experimental | 1995 |
Suppression of tyrosinase gene expression by bromodeoxyuridine in Syrian hamster melanoma cells is not due to its incorporation into upstream or coding sequences of the tyrosinase gene.
Topics: Animals; Binding Sites; Bromodeoxyuridine; Chloramphenicol O-Acetyltransferase; Cricetinae; DNA; Gene Expression; Humans; Melanins; Melanoma, Experimental; Mesocricetus; Monophenol Monooxygenase; Promoter Regions, Genetic; Tumor Cells, Cultured | 1993 |
5-Propyl-2-deoxyuridine induced interference with glycosylation in herpes simplex virus infected cells. Nature of PdU-induced modifications of N-linked glycans.
Topics: Agglutinins; Animals; Antiviral Agents; Biological Transport; Bromodeoxyuridine; Cell Line; Chlorocebus aethiops; Chromatography, Affinity; Chromatography, Gel; Deoxyuridine; Glycosylation; Golgi Apparatus; Humans; Infant; Lectins; Melanoma, Experimental; Mice; Neuraminidase; Nucleoside Diphosphate Sugars; Polysaccharides; Simplexvirus; Tumor Cells, Cultured; Viral Envelope Proteins | 1993 |
Bromodeoxyuridine improves the cytotoxic effect of cisplatin: a comparison with 5-fluorouracil.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cisplatin; Drug Synergism; Fluorouracil; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Tumor Cells, Cultured | 1997 |
Induction of p53 and melanoma cell death is reciprocal with down-regulation of E2F, cyclin D1 and pRB.
Topics: Animals; Bromodeoxyuridine; Carrier Proteins; Cell Cycle; Cell Cycle Proteins; Cell Death; Cell Survival; Cyclin D1; DNA Damage; DNA-Binding Proteins; DNA, Neoplasm; Down-Regulation; E2F Transcription Factors; Gene Expression Regulation, Neoplastic; Melanoma, Experimental; Mice; Radiation-Sensitizing Agents; Retinoblastoma Protein; Retinoblastoma-Binding Protein 1; Transcription Factor DP1; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Ultraviolet Rays | 1998 |
Blue light inhibits the growth of B16 melanoma cells.
Topics: Animals; Bromodeoxyuridine; Cell Death; Cell Division; Coloring Agents; Flow Cytometry; G1 Phase; G2 Phase; Light; Melanoma, Experimental; Mice; Mitosis; Resting Phase, Cell Cycle; S Phase; Time Factors; Tumor Cells, Cultured; Ultraviolet Rays | 2002 |
Bromodeoxyuridine- and cyclic AMP-mediated regulation of tyrosinase in Syrian hamster melanoma cells.
Topics: Animals; Blotting, Northern; Bromodeoxyuridine; Bucladesine; Cricetinae; Cricetulus; Cyclic AMP; Gene Expression; In Vitro Techniques; Melanocyte-Stimulating Hormones; Melanoma, Experimental; Monophenol Monooxygenase; Pigmentation; RNA, Messenger; Tumor Cells, Cultured | 1990 |
Tumor hypersensitive DNA is enriched in c-myc sequences and reacts differentially with normal and malignant genomic DNA.
Topics: Animals; Blotting, Southern; Bromodeoxyuridine; Cell Line; Deoxyribonuclease I; DNA Polymerase I; DNA Repair; DNA, Neoplasm; Melanoma, Experimental; Mice; Nucleic Acid Hybridization; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myc; Proto-Oncogenes | 1990 |
Differential response of adherent and unanchored melanoma cells to bromodeoxyuridine evidenced by specific lectin-binding protein changes.
Topics: Animals; Bromodeoxyuridine; Cell Line; Melanoma, Experimental; Mice; Molecular Weight; Receptors, Mitogen; Tumor Cells, Cultured | 1989 |
Cellular sialic acid level and phenotypic expression in B16 melanoma cells: comparison of spontaneous variations and bromodeoxyuridine- and theophylline-induced changes.
Topics: Animals; Bromodeoxyuridine; Cell Adhesion; Melanoma, Experimental; Mice; N-Acetylneuraminic Acid; Phenotype; Sialic Acids; Theophylline; Tumor Cells, Cultured | 1989 |
Identification of 'non-proliferating' B16 melanoma cells using monoclonal antibody (AD203) against the M1 subunit of ribonucleotide reductase.
Topics: Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Transformation, Neoplastic; DNA; Immunohistochemistry; Melanoma, Experimental; Mice; Ribonucleotide Reductases; Tumor Cells, Cultured | 1988 |
Population changes of human somatic cells in culture during short-term treatment with drugs.
Topics: Azaguanine; Bromodeoxyuridine; Cell Count; Cell Nucleus; Choroid; Chromosomes, Human; Humans; Karyotyping; Melanoma, Experimental; Mitotic Index; Time Factors; Tumor Cells, Cultured | 1987 |